EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma
Mon, 1st Mar 2021 16:41
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:
Sensyne Health PLC - Oxford, England-based clinical technology using artificial intelligence - Moves Chief Investment Officer Richard Pye to chief financial officer and executive director, while interim CFO Michael Norris moves to non-executive director, both from last Friday. Norris has been interim CFO since March last year. Additionally, Geoff Race joins the board as non-executive director. Race is co-founder and CFO of Nasdaq-listed biopharmaceutical company Minerva Neurosciences Inc.